Software for complex group sequential designs
Contemporary Clinical Trials · 2025
DOI: 10.1016/j.cct.2025.107994 ↗Kurz gefasst
Fachartikel in der Zeitschrift Contemporary Clinical Trials, 2025. Verfasst von Yujie Zhao und 1 weiteren Autor:innen. Beteiligte Einrichtung: Merck & Co., Inc., Rahway, NJ, USA. Hauptthemen laut MEDLINE: Software, Research Design, Clinical Trials as Topic. Die Arbeit nennt 9 Literaturangaben.
Abstract (Originalsprache)
Group sequential design (GSD) is a statistical methodology employed in clinical trials to enable interim analyses (IA) and potential early termination based on accumulating data. It has gained significant popularity in the field of clinical trials due to its ability to enhance decision-making and expedite the development of effective treatments. The implementation of GSD has grown progressively intricate in recent times. For instance, in several recent trials, the treatment effect may vary over both time and strata. Given the complexity of GSD, it is crucial to have appropriate software that facilitates the necessary calculations. This article will introduce R packages for GSD using both examples and simulations, notably gsDesign2 and simtrial.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Merck & Co., Inc., Rahway, NJ, USA.
Zitieren
APA
Zhao, Y., & Anderson, K. (2025). Software for complex group sequential designs. Contemporary Clinical Trials. https://doi.org/10.1016/j.cct.2025.107994
Vancouver
Zhao Y, Anderson K. Software for complex group sequential designs. Contemporary Clinical Trials. 2025. doi:10.1016/j.cct.2025.107994
BibTeX
@article{Zhao2025,
author = {Zhao, Yujie and Anderson, Keaven},
title = {Software for complex group sequential designs},
journal = {Contemporary Clinical Trials},
year = {2025},
doi = {10.1016/j.cct.2025.107994}
}
EUVIMED